Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: Cohort evaluation within a randomized phase II study

Annals of Surgical Oncology

Volumn 21, Issue SUPPL. 3, 2014, Pages

  Yoshikawa, Takaki ^a   Tanabe, Kazuaki ^b   Nishikawa, Kazuhiro ^c   Ito, Yuichi ^d   Matsui, Takanori ^d   Kimura, Yutaka ^e   Hasegawa, Shinichi ^a   Aoyama, Toru ^a   Hayashi, Tsutomu ^a   Morita, Satoshi ^f   Miyashita, Yumi ^g   Tsuburaya, Akira ^h   Sakamoto, Junichi ⁱ  

^a KANAGAWA CANCER CENTER   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e OSAKA POLICE HOSPITAL   (Japan)

^f YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^g Data Center Nonprofit Organization ECRIN   (Japan)

^h SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

ⁱ Tokai Central Hospital of Japan Mutual Aid Association of Public School Teachers   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; PACLITAXEL; ANTINEOPLASTIC AGENT; DRUG COMBINATION; OTERACIL; S 1 (COMBINATION); TEGAFUR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL DECISION MAKING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EVALUATION STUDY; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; TREATMENT RESPONSE; VERY ELDERLY; CANCER PATIENT; LYMPH NODE DISSECTION; RELIABILITY; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; ADJUVANT THERAPY; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; DRUG COMBINATION; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OXONIC ACID; PACLITAXEL; PROGNOSIS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84903271797     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3615-8     Document Type: Article

References (23)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
2. Yoshikawa T, Rino Y, Yukawa N, Oshima T, Tsuburaya A, Masuda M. Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy. Surg Today. 2014;44:11-21.
3. Yoshikawa T, Sasako M. Gastrointestinal cancer: adjuvant chemotherapy after D2 gastrectomy for gastric cancer. Nat Rev Clin Oncol. 2012;9:192-4.
4. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810-20. (Pubitemid 350044801)
5. Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387-93.
6. Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315-21.
7. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Gastric Cancer Version 2.2011. http://www.nccn.org/ professionals/physician-gls/pdf/gastric.pdf. Accessed 25 Apr 2013.
8. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60:1449-72.
9. Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol. 2007;25:2107-16. (Pubitemid 46972798)
10. Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12:6-22.
11. Ajani JA, Mansfield PF, Lynch PM, et al. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol. 1999;17:2403-11. (Pubitemid 29368239)
12. Kelsen D, Karpeh M, Schwartz G, et al. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol. 1996;14:1818-28. (Pubitemid 26185457)
13. Park SR, Lee JS, Kim CG, et al. Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer. 2008;112:2368-76.
14. Yoshikawa T, Tsuburaya A, Morita S, et al. A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized phase II trial (COMPASS). Jpn J Clin Oncol. 2010;40:369-72.
15. Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215-21.
16. Tsuburaya A, Nagata N, Cho H, et al. Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer. Cancer Chemother Pharmacol. 2013;71:1309-14.
17. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113-23.
18. Habermann CR, Weiss F, Riecken R, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology. 2004;230:465-71. (Pubitemid 38133808)
19. Hasegawa S, Yoshikawa T, Shirai J, et al. A prospective validation study to diagnose serosal invasion and nodal metastases of gastric cancer by multidetector-row CT. Ann Surg Oncol. 2013;20:2016-22.
20. Sobin LH, Compton CC. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer. 2010;116:5336-9.
21. Sobin LH, Gospodarowicz MK, Witterkind CH. International Union against Cancer (UICC) TNM classification of malignant tumors. 7th ed. Oxford, UK: Wiley-Blackwell; 2009.
22. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-16.
23. Yonemura Y, Kinoshita K, Fujimura T, et al. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients. Hepatogastroenterology. 1996;43:1260-72. (Pubitemid 26358524)